Succimer

Succimer (CAS No.: 304-55-2) is a small-molecule dithiol chelating agent widely utilized in biomedical research and clinical pharmacology for the detoxification of heavy metals, particularly lead. Its primary mechanism of action involves the formation of stable, water-soluble complexes with metal ions, thereby facilitating their mobilization and excretion while reducing systemic toxicity. Succimer has demonstrated robust efficacy in experimental models of lead exposure, significantly lowering blood and tissue lead levels across multiple organs, including the brain, liver, and kidneys, and modulating oxidative stress markers such as catalase and glucose-6-phosphate dehydrogenase activity. In addition to its established role in lead chelation, it has been shown to counteract arsenite-induced inhibition of mitochondrial enzymes such as pyruvate dehydrogenase and to mitigate nephrotoxicity and apoptosis associated with platinum-based compounds, indicating broader protective effects against metal-induced cellular injury. Its activity is typically observed in the low micromolar to millimolar range in vitro, depending on the assay system and target metal species. Owing to its favorable safety profile and specificity, Succimer is extensively employed in cell-based and animal models to investigate metal toxicokinetics, oxidative stress pathways, and therapeutic chelation strategies, as well as in drug discovery efforts aimed at developing improved agents for heavy metal detoxification. Experimental concentrations or dosing regimens vary according to study design and biological context.